This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Kyouichi Hirotsu: Pharmaceutical Invention and Patent
Introduction
Kyouichi Hirotsu is an inventor associated with Fukuoka, Japan, and Yoshitomi Pharmaceutical Industries, Ltd. His recorded patent work concerns an oral antitumor composition designed to improve the absorption of an antitumor agent.
Latest Patents
Hirotsu is associated with 1 patent, titled “Antitumor Composition for Oral Administration.” The invention combines a 2′-deoxy-2′-methylidenecytidine (DMDC) compound, or an acid addition salt or hydrate of that compound, with a sucrose ester of fatty acids. The patent describes the composition as having improved oral absorption while retaining the compound’s antitumor activity against solid tumors.
Career Highlights
Hirotsu’s listed patent reflects pharmaceutical research focused on developing an orally administered formulation of an antitumor agent. His work is associated with Yoshitomi Pharmaceutical Industries, Ltd.
Collaborations
Hirotsu’s listed coworkers include Hirotsugu Tada and Toshiyuki Shibata. Their names are associated with the patent record for the antitumor composition.
Conclusion
Kyouichi Hirotsu’s recorded invention addresses the formulation and oral absorption of a DMDC-based antitumor composition, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile